FDA Approves First Gene Therapy for Adults with Severe Hemophilia A
U.S. Food and Drug Administration
Roctavian recipients should be closely monitored for infusion-related reactions and liver enzyme elevation
Hematology
First-Ever FISH Probes for Patient Management Granted IVDR Certification
Oxford Gene Technology
IVDR-compliant products help boost patient safety as well as future-proof customer supply chains
Overcoming Challenges for Predicting Interactions between Cancerous Cells and Red Blood Cells
Amanda Randles, PhD
Robust sampling strategies and suitable metrics may improve accuracy
Researchers Trial Potential Hemophilia Treatment
McMaster University
Patients with hemophilia A may now only need once-weekly, instead of thrice-weekly, injections of factor VIII
FDA Proposes New Blood Donor Assessment Model
Swathi Kodaikal, MSc
Most LGBTQ+ advocates welcome FDA’s proposed blood donor eligibility guidance, despite its flaws
New, Robust, LC-MS-MS-Based Tool Detects Antidepressants in Blood
Brown University
The technique needs only 20 μl of sample and can be configured to run on most liquid handling systems
Best Practices for Blood Banking
Today's Clinical Lab
Download this application note to learn about the different conditions for blood banking, and how you can ensure these conditions in your lab
Guidelines Must Change to Make Transfusion Medicine Gender Inclusive
Carlo Ledesma, MS, MLS(ASCP)SH, DLM, QLS, MLS(AMT)
Current blood transfusion guidelines pose significant concerns for transgender and nonbinary people and need to be updated
Researchers Boost Accuracy of Home-Based Continuous Glucose Monitoring
Tsinghua University Press
Research aim to improve glucose-sensing using colloidal quantum dots
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B
U.S. Food and Drug Administration
The one-time gene therapy, Hemgenix, was evaluated in two studies and was found to decrease annualized bleeding rate